Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of RPG LIFE SCIENCES. For more details, see the RPG LIFE SCIENCES quarterly results and RPG LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.4 |
No. of shares | m | 16.54 |
1 Week | % | 3.0 |
1 Month | % | 2.0 |
1 Year | % | 91.0 |
52 week H/L | Rs | 1,740.0/745.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
RPG LIFE SCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 442 | 351 | 456 | 752 | 1,012 | |
Low | Rs | 202 | 146 | 169 | 375 | 452 | |
Sales per share (Unadj.) | Rs | 199.6 | 227.1 | 235.3 | 266.1 | 310.0 | |
Earnings per share (Unadj.) | Rs | 6.5 | 17.5 | 24.2 | 31.1 | 40.9 | |
Diluted earnings per share | Rs | 6.5 | 17.5 | 24.2 | 31.1 | 40.9 | |
Cash flow per share (Unadj.) | Rs | 15.8 | 27.4 | 34.1 | 40.6 | 50.3 | |
Dividends per share (Unadj.) | Rs | 2.40 | 4.00 | 7.20 | 9.60 | 12.00 | |
Adj. dividends per share | Rs | 2.40 | 4.00 | 7.20 | 9.60 | 12.00 | |
Avg Dividend yield | % | 0.7 | 1.6 | 2.3 | 1.7 | 1.6 | |
Book value per share (Unadj.) | Rs | 97.0 | 106.8 | 130.9 | 154.6 | 186.0 | |
Adj. book value per share | Rs | 97.0 | 106.8 | 130.9 | 154.6 | 186.0 | |
Shares outstanding (eoy) | m | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 | |
Price / Sales ratio | x | 1.6 | 1.1 | 1.3 | 2.1 | 2.4 | |
Avg P/E ratio | x | 49.2 | 14.2 | 12.9 | 18.1 | 17.9 | |
P/CF ratio (eoy) | x | 20.4 | 9.1 | 9.2 | 13.9 | 14.6 | |
Price / Book Value ratio | x | 3.3 | 2.3 | 2.4 | 3.6 | 3.9 | |
Dividend payout | % | 36.7 | 22.8 | 29.8 | 30.8 | 29.3 | |
Avg Mkt Cap | Rs m | 5,323 | 4,110 | 5,171 | 9,317 | 12,109 | |
Total wages/salary | Rs m | 899 | 910 | 947 | 1,000 | 1,171 |
RPG LIFE SCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,302 | 3,756 | 3,891 | 4,402 | 5,128 | |
Other income | Rs m | 8 | 10 | 11 | 31 | 48 | |
Total revenues | Rs m | 3,310 | 3,766 | 3,902 | 4,432 | 5,176 | |
Gross profit | Rs m | 344 | 546 | 708 | 872 | 1,035 | |
Depreciation | Rs m | 153 | 164 | 165 | 157 | 155 | |
Interest | Rs m | 49 | 28 | 18 | 14 | 12 | |
Profit before tax | Rs m | 151 | 365 | 536 | 732 | 917 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 42 | 74 | 136 | 217 | 240 | |
Profit after tax | Rs m | 108 | 290 | 400 | 515 | 676 | |
Gross profit margin | % | 10.4 | 14.5 | 18.2 | 19.8 | 20.2 | |
Effective tax rate | % | 28.2 | 20.4 | 25.3 | 29.6 | 26.2 | |
Net profit margin | % | 3.3 | 7.7 | 10.3 | 11.7 | 13.2 |
RPG LIFE SCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 971 | 1,258 | 1,759 | 2,069 | 2,641 | |
Current liabilities | Rs m | 778 | 826 | 797 | 801 | 1,028 | |
Net working cap to sales | % | 5.8 | 11.5 | 24.7 | 28.8 | 31.4 | |
Current ratio | x | 1.2 | 1.5 | 2.2 | 2.6 | 2.6 | |
Inventory Days | Days | 7 | 9 | 2 | 2 | 46 | |
Debtors Days | Days | 430 | 615 | 539 | 274 | 266 | |
Net fixed assets | Rs m | 1,508 | 1,421 | 1,275 | 1,377 | 1,553 | |
Share capital | Rs m | 132 | 132 | 132 | 132 | 132 | |
"Free" reserves | Rs m | 1,473 | 1,633 | 2,032 | 2,425 | 2,944 | |
Net worth | Rs m | 1,605 | 1,766 | 2,165 | 2,558 | 3,076 | |
Long term debt | Rs m | 66 | 15 | 7 | 3 | 0 | |
Total assets | Rs m | 2,479 | 2,679 | 3,033 | 3,446 | 4,194 | |
Interest coverage | x | 4.1 | 14.2 | 30.9 | 52.9 | 80.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.3 | 1.4 | 1.3 | 1.3 | 1.2 | |
Return on assets | % | 6.3 | 11.9 | 13.8 | 15.3 | 16.4 | |
Return on equity | % | 6.7 | 16.4 | 18.5 | 20.1 | 22.0 | |
Return on capital | % | 11.9 | 22.0 | 25.5 | 29.1 | 30.2 | |
Exports to sales | % | 37.8 | 31.7 | 33.0 | 32.4 | 31.7 | |
Imports to sales | % | 4.3 | 4.0 | 4.9 | 3.6 | 3.9 | |
Exports (fob) | Rs m | 1,248 | 1,191 | 1,283 | 1,428 | 1,624 | |
Imports (cif) | Rs m | 141 | 150 | 191 | 160 | 201 | |
Fx inflow | Rs m | 1,248 | 1,191 | 1,283 | 1,428 | 1,624 | |
Fx outflow | Rs m | 141 | 150 | 191 | 160 | 201 | |
Net fx | Rs m | 1,107 | 1,042 | 1,092 | 1,268 | 1,424 |
RPG LIFE SCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 458 | 502 | 583 | 648 | 908 | |
From Investments | Rs m | -190 | -107 | -80 | -347 | -1,058 | |
From Financial Activity | Rs m | -265 | -393 | -105 | -135 | -171 | |
Net Cashflow | Rs m | 3 | 2 | 398 | 166 | -321 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: H V Goenka | COMP SEC: Rajesh Shirambekar | YEAR OF INC: 2007 | BSE CODE: 532983 | FV (Rs): 8 | DIV YIELD (%): 0.8 |
Read: RPG LIFE SCIENCES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare RPG LIFE SCIENCES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.